Experienced in Secondary Immunodeficiency (SID)

Dr. Antoinette M. Moran

Pediatric Endocrinology | Pediatrics
420 Delaware St Se, Mmc 404, University Of Minnesota Physicians, 
Minneapolis, MN 
Accepting New Patients
Experienced in Secondary Immunodeficiency (SID)
420 Delaware St Se, Mmc 404, University Of Minnesota Physicians, 
Minneapolis, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Antoinette Moran is a Pediatric Endocrinologist and a Pediatrics provider in Minneapolis, Minnesota. Dr. Moran is rated as an Experienced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Type 1 Diabetes (T1D), Congenital Hyperinsulinism, Chronic Pancreatitis, Pancreatectomy, and Islet Cell Transplantation. Dr. Moran is currently accepting new patients.

Her clinical research consists of co-authoring 116 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Endocrinology
Pediatrics
Licenses
Pediatrics in MN
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
PreferredOne
  • HMO
  • OTHER COMMERCIAL
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 9 Less Insurance Carriers -

Locations

420 Delaware St Se, Mmc 404, University Of Minnesota Physicians, Minneapolis, MN 55455

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 20, 2025
Intervention Type: Other, Drug
Study Drugs: Pre-Proinsulin, TGF-Beta1, IL-10, IL-2
Study Phase: Phase 1
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer)
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer)
Enrollment Status: Completed
Publish Date: November 27, 2024
Intervention Type: Drug, Device
Study Drug: Verapamil
Study Phase: Phase 3
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes
Enrollment Status: Completed
Publish Date: June 06, 2024
Intervention Type: Drug
Study Drug: CTLA4-Ig (Abatacept)
Study Phase: Phase 2
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Completed
Publish Date: February 01, 2023
Intervention Type: Biological, Drug
Study Drugs: AG019 - Low Dose, Teplizumab, AG019 - High Dose, AG019 - Low or High Dose
Study Phase: Phase 1/Phase 2
Preserving Beta-Cell Function With Tocilizumab in New-onset Type 1 Diabetes (ITN058AI)
Preserving Beta-Cell Function With Tocilizumab in New-onset Type 1 Diabetes (ITN058AI)
Enrollment Status: Completed
Publish Date: September 08, 2021
Intervention Type: Drug, Other
Study Phase: Phase 2
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
View 5 Less Clinical Trials

116 Total Publications

Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes.
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes.
Journal: Diabetes
Published: September 02, 2025
Similar Doctors
Experienced in Secondary Immunodeficiency (SID)
Dr. Brooke M. Moore
Pediatric Pulmonology | Pulmonary Medicine | Pediatrics
Experienced in Secondary Immunodeficiency (SID)
Dr. Brooke M. Moore
Pediatric Pulmonology | Pulmonary Medicine | Pediatrics

Children's Respiratory And Critical Care Specialists PA

2530 Chicago Ave, Suite 400, 
Minneapolis, MN 
 (1.8 miles away)
612-813-3300
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Brooke Moore is a Pediatric Pulmonologist and a Pulmonary Medicine provider in Minneapolis, Minnesota. Dr. Moore is rated as an Experienced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Asthma in Children, Asthma, Congenital Unilateral Pulmonary Hypoplasia, and Cystic Fibrosis. Dr. Moore is currently accepting new patients.

Experienced in Secondary Immunodeficiency (SID)
Dr. Samuel B. Goldfarb
Pediatric Pulmonology | Pediatrics
Experienced in Secondary Immunodeficiency (SID)
Dr. Samuel B. Goldfarb
Pediatric Pulmonology | Pediatrics
2450 Riverside Ave, 
Minneapolis, MN 
 (0.4 miles away)
612-365-8061
Languages Spoken:
English, Hebrew
See accepted insurances
Accepting New Patients

Samuel Goldfarb is a Pediatric Pulmonologist and a Pediatrics provider in Minneapolis, Minnesota. Dr. Goldfarb is rated as an Advanced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Congenital Unilateral Pulmonary Hypoplasia, Cystic Fibrosis, Lung Transplant, and Advanced Bronchoscopy. Dr. Goldfarb is currently accepting new patients.

Experienced in Secondary Immunodeficiency (SID)
Dr. Daniela Zgherea
Pediatric Pulmonology | Pediatrics | Pulmonary Medicine
Experienced in Secondary Immunodeficiency (SID)
Dr. Daniela Zgherea
Pediatric Pulmonology | Pediatrics | Pulmonary Medicine

Children's Respiratory And Critical Care Specialists PA

2530 Chicago Ave, Suite 400, 
Minneapolis, MN 
 (1.8 miles away)
612-813-3300
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Daniela Zgherea is a Pediatric Pulmonologist and a Pediatrics provider in Minneapolis, Minnesota. Dr. Zgherea is rated as an Experienced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Tracheoesophageal Fistula, Laryngomalacia, Asthma, Subglottic Stenosis, and Myringotomy. Dr. Zgherea is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Moran's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile